Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell cycle-specific effects of lovastatin.

M Jakóbisiak1, S Bruno, J S Skierski

  • 1Sloan-Kettering Institute for Cancer Research, New York, NY 10021.

Proceedings of the National Academy of Sciences of the United States of America
|May 1, 1991
PubMed
Summary

Lovastatin inhibits cell growth by arresting the cell cycle in G1 and G2 phases, potentially by affecting p21ras signaling. These effects are reversible with mevalonate, suggesting a role for mevalonate pathway inhibition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into pedigree- and genome-based inbreeding patterns in Martina Franca donkey breed.

Animal : an international journal of animal bioscience·2025
Same author

Best practices to reduce microbial contamination during media-fill testing process in hospital pharmacies: a scoping review of literature.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2025
Same author

Looking at the Therapeutic Change Through a Textual Analysis: Evidence from an Online Group Analytic Treatment.

International journal of group psychotherapy·2025
Same author

Perceived relevance of Planetary Health for Medical Students in Italy: Results from a mixed-methods analysis.

Public health in practice (Oxford, England)·2025
Same author

Minimally invasive management of chronic venous insufficiency: A case report on combined radiofrequency ablation and sclerotherapy in an obese patient.

International journal of surgery case reports·2025
Same author

Associations between post-traumatic stress symptoms and sleep/circadian parameters: Exploring the effect of chronotype as a moderator variable.

Chronobiology international·2023

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Lovastatin (LOV) is a hypercholesteremia drug that inhibits mevalonic acid synthesis.
  • The p21ras protein is crucial for cell signaling and membrane attachment via isoprenylation.
  • Understanding LOV's impact on cancer cell cycle progression is vital for therapeutic development.

Purpose of the Study:

  • To investigate the effects of Lovastatin on the cell cycle of human bladder carcinoma T24 cells.
  • To explore the role of p21ras and mevalonate pathway in LOV-induced cell cycle arrest.

Main Methods:

  • Treated T24 bladder cancer cells with varying concentrations of Lovastatin (2-50 microM).
  • Assessed cell cycle progression, viability, RNA/protein content, and chromatin condensation.

Related Experiment Videos

  • Quantified expression of proliferation markers (Ki-67, p105) and p21ras localization.
  • Evaluated the effect of exogenous mevalonate and LOV removal on cell cycle.

    • Main Results:

    • Lovastatin (2-10 microM) induced G1 and G2 cell cycle arrest, with 50 microM showing cytotoxicity.
    • Cytostatic effects were reversible upon addition of mevalonate.
    • LOV reduced Ki-67 and p105 expression by up to 74% and altered p21ras localization from the cell membrane.
    • Cells resumed cell cycle progression after LOV removal, entering S phase asynchronously.

    Conclusions:

    • Lovastatin-induced G1 arrest in T24 cells may stem from impaired p21ras signal transduction due to inhibited isoprenylation.
    • Alternative mechanisms involving the inhibition of other protein isoprenylation (e.g., nuclear lamins) could also contribute to growth suppression.
    • Lovastatin exhibits cytostatic effects on bladder cancer cells, highlighting the potential of targeting the mevalonate pathway.